Efficacy of topical nerve growth factor treatment in dogs affected by dry eye

Marco Coassin, Alessandro Lambiase, Nicola Costa, Alessandra De Gregorio, Roberto Sgrulletta, Marta Sacchetti, Luigi Aloe, Stefano Bonini

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Preliminary data show that nerve growth factor (NGF) may improve tear production in humans. We evaluated the efficacy of topical NGF treatment in dogs who developed dry eye after the excision of the third eyelid lacrimal gland. Methods: English Bulldogs (2- to 6-year-old males and females) that had undergone the surgical removal of the prolapsed lacrimal gland of the third eyelid in both eyes at the age of 3-6 months developed chronic keratoconjunctivitis sicca associated with a decrease of Schirmer tear test I values after at least 1 year. One eye, randomly selected, of each dog was treated twice daily with 100±l of NGF ointment for 1 month, while the fellow eye was used as control and treated with the ointment vehicle only. At baseline and after 1 month of NGF treatment the following examinations were performed: corneal evaluation by slit lamp, fluorescein staining, Schirmer tear test I, tear ferning test, corneal esthesiometry by cotton swab and conjunctival impression cytology. Results: Topical application of NGF caused a significant impr ovement of all the evaluated parameters compared with baseline values. In contrast, in the control eyes there was no significant difference between the values measured before and after treatment. In particular, after NGF treatment superficial punctate keratopathy was resolved, corneal haze was reduced from stage 4 to stage 2 and Schirmer test values increased (17.2±1.7 mm/min vs 4.5±1.3 mm/min; p

Original languageEnglish
Pages (from-to)151-155
Number of pages5
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume243
Issue number2
DOIs
Publication statusPublished - Feb 2005

Fingerprint

Nerve Growth Factor
Dogs
Tears
Nictitating Membrane
Lacrimal Apparatus
Ointments
Therapeutics
Keratoconjunctivitis Sicca
Fluorescein
Cell Biology
Staining and Labeling

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Coassin, M., Lambiase, A., Costa, N., De Gregorio, A., Sgrulletta, R., Sacchetti, M., ... Bonini, S. (2005). Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefe's Archive for Clinical and Experimental Ophthalmology, 243(2), 151-155. https://doi.org/10.1007/s00417-004-0955-2

Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. / Coassin, Marco; Lambiase, Alessandro; Costa, Nicola; De Gregorio, Alessandra; Sgrulletta, Roberto; Sacchetti, Marta; Aloe, Luigi; Bonini, Stefano.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 243, No. 2, 02.2005, p. 151-155.

Research output: Contribution to journalArticle

Coassin, M, Lambiase, A, Costa, N, De Gregorio, A, Sgrulletta, R, Sacchetti, M, Aloe, L & Bonini, S 2005, 'Efficacy of topical nerve growth factor treatment in dogs affected by dry eye', Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 243, no. 2, pp. 151-155. https://doi.org/10.1007/s00417-004-0955-2
Coassin, Marco ; Lambiase, Alessandro ; Costa, Nicola ; De Gregorio, Alessandra ; Sgrulletta, Roberto ; Sacchetti, Marta ; Aloe, Luigi ; Bonini, Stefano. / Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2005 ; Vol. 243, No. 2. pp. 151-155.
@article{e2f80e427fe948e38e9539d596f4883c,
title = "Efficacy of topical nerve growth factor treatment in dogs affected by dry eye",
abstract = "Background: Preliminary data show that nerve growth factor (NGF) may improve tear production in humans. We evaluated the efficacy of topical NGF treatment in dogs who developed dry eye after the excision of the third eyelid lacrimal gland. Methods: English Bulldogs (2- to 6-year-old males and females) that had undergone the surgical removal of the prolapsed lacrimal gland of the third eyelid in both eyes at the age of 3-6 months developed chronic keratoconjunctivitis sicca associated with a decrease of Schirmer tear test I values after at least 1 year. One eye, randomly selected, of each dog was treated twice daily with 100±l of NGF ointment for 1 month, while the fellow eye was used as control and treated with the ointment vehicle only. At baseline and after 1 month of NGF treatment the following examinations were performed: corneal evaluation by slit lamp, fluorescein staining, Schirmer tear test I, tear ferning test, corneal esthesiometry by cotton swab and conjunctival impression cytology. Results: Topical application of NGF caused a significant impr ovement of all the evaluated parameters compared with baseline values. In contrast, in the control eyes there was no significant difference between the values measured before and after treatment. In particular, after NGF treatment superficial punctate keratopathy was resolved, corneal haze was reduced from stage 4 to stage 2 and Schirmer test values increased (17.2±1.7 mm/min vs 4.5±1.3 mm/min; p",
author = "Marco Coassin and Alessandro Lambiase and Nicola Costa and {De Gregorio}, Alessandra and Roberto Sgrulletta and Marta Sacchetti and Luigi Aloe and Stefano Bonini",
year = "2005",
month = "2",
doi = "10.1007/s00417-004-0955-2",
language = "English",
volume = "243",
pages = "151--155",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Efficacy of topical nerve growth factor treatment in dogs affected by dry eye

AU - Coassin, Marco

AU - Lambiase, Alessandro

AU - Costa, Nicola

AU - De Gregorio, Alessandra

AU - Sgrulletta, Roberto

AU - Sacchetti, Marta

AU - Aloe, Luigi

AU - Bonini, Stefano

PY - 2005/2

Y1 - 2005/2

N2 - Background: Preliminary data show that nerve growth factor (NGF) may improve tear production in humans. We evaluated the efficacy of topical NGF treatment in dogs who developed dry eye after the excision of the third eyelid lacrimal gland. Methods: English Bulldogs (2- to 6-year-old males and females) that had undergone the surgical removal of the prolapsed lacrimal gland of the third eyelid in both eyes at the age of 3-6 months developed chronic keratoconjunctivitis sicca associated with a decrease of Schirmer tear test I values after at least 1 year. One eye, randomly selected, of each dog was treated twice daily with 100±l of NGF ointment for 1 month, while the fellow eye was used as control and treated with the ointment vehicle only. At baseline and after 1 month of NGF treatment the following examinations were performed: corneal evaluation by slit lamp, fluorescein staining, Schirmer tear test I, tear ferning test, corneal esthesiometry by cotton swab and conjunctival impression cytology. Results: Topical application of NGF caused a significant impr ovement of all the evaluated parameters compared with baseline values. In contrast, in the control eyes there was no significant difference between the values measured before and after treatment. In particular, after NGF treatment superficial punctate keratopathy was resolved, corneal haze was reduced from stage 4 to stage 2 and Schirmer test values increased (17.2±1.7 mm/min vs 4.5±1.3 mm/min; p

AB - Background: Preliminary data show that nerve growth factor (NGF) may improve tear production in humans. We evaluated the efficacy of topical NGF treatment in dogs who developed dry eye after the excision of the third eyelid lacrimal gland. Methods: English Bulldogs (2- to 6-year-old males and females) that had undergone the surgical removal of the prolapsed lacrimal gland of the third eyelid in both eyes at the age of 3-6 months developed chronic keratoconjunctivitis sicca associated with a decrease of Schirmer tear test I values after at least 1 year. One eye, randomly selected, of each dog was treated twice daily with 100±l of NGF ointment for 1 month, while the fellow eye was used as control and treated with the ointment vehicle only. At baseline and after 1 month of NGF treatment the following examinations were performed: corneal evaluation by slit lamp, fluorescein staining, Schirmer tear test I, tear ferning test, corneal esthesiometry by cotton swab and conjunctival impression cytology. Results: Topical application of NGF caused a significant impr ovement of all the evaluated parameters compared with baseline values. In contrast, in the control eyes there was no significant difference between the values measured before and after treatment. In particular, after NGF treatment superficial punctate keratopathy was resolved, corneal haze was reduced from stage 4 to stage 2 and Schirmer test values increased (17.2±1.7 mm/min vs 4.5±1.3 mm/min; p

UR - http://www.scopus.com/inward/record.url?scp=14944366026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944366026&partnerID=8YFLogxK

U2 - 10.1007/s00417-004-0955-2

DO - 10.1007/s00417-004-0955-2

M3 - Article

VL - 243

SP - 151

EP - 155

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 2

ER -